JP2010501580A5 - - Google Patents

Download PDF

Info

Publication number
JP2010501580A5
JP2010501580A5 JP2009525662A JP2009525662A JP2010501580A5 JP 2010501580 A5 JP2010501580 A5 JP 2010501580A5 JP 2009525662 A JP2009525662 A JP 2009525662A JP 2009525662 A JP2009525662 A JP 2009525662A JP 2010501580 A5 JP2010501580 A5 JP 2010501580A5
Authority
JP
Japan
Prior art keywords
amino acids
amino
sequence
core
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009525662A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010501580A (ja
JP5474547B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/018940 external-priority patent/WO2008024518A2/en
Publication of JP2010501580A publication Critical patent/JP2010501580A/ja
Publication of JP2010501580A5 publication Critical patent/JP2010501580A5/ja
Application granted granted Critical
Publication of JP5474547B2 publication Critical patent/JP5474547B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009525662A 2006-08-25 2007-08-27 Ｈｃｖ融合ポリペプチド Active JP5474547B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84016206P 2006-08-25 2006-08-25
US60/840,162 2006-08-25
PCT/US2007/018940 WO2008024518A2 (en) 2006-08-25 2007-08-27 Hcv fusion polypeptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013241514A Division JP2014036675A (ja) 2006-08-25 2013-11-22 Ｈｃｖ融合ポリペプチド

Publications (3)

Publication Number Publication Date
JP2010501580A JP2010501580A (ja) 2010-01-21
JP2010501580A5 true JP2010501580A5 (https=) 2010-11-11
JP5474547B2 JP5474547B2 (ja) 2014-04-16

Family

ID=38969483

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009525662A Active JP5474547B2 (ja) 2006-08-25 2007-08-27 Ｈｃｖ融合ポリペプチド
JP2013241514A Withdrawn JP2014036675A (ja) 2006-08-25 2013-11-22 Ｈｃｖ融合ポリペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013241514A Withdrawn JP2014036675A (ja) 2006-08-25 2013-11-22 Ｈｃｖ融合ポリペプチド

Country Status (5)

Country Link
US (1) US8216590B2 (https=)
EP (1) EP2061888A2 (https=)
JP (2) JP5474547B2 (https=)
CA (1) CA2661492A1 (https=)
WO (1) WO2008024518A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011163558A1 (en) * 2010-06-25 2011-12-29 Abbott Laboratories Materials and methods for assay of anti-hepatitis c virus (hcv) antibodies
EP4516312A3 (en) 2015-07-07 2025-04-30 The Governors Of The University Of Alberta Hepatitis c virus immunogenic compositions and methods of use thereof
EP3515483A4 (en) 2016-09-21 2020-12-16 The Governors of the University of Alberta HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND THEIR USE PROCEDURES
BR102018071672A2 (pt) * 2018-10-22 2021-11-16 Fundação Oswaldo Cruz Polipeptídeo, cassete de expressão, vetor de expressão, célula hospedeira, kit para triagem imunológica de hcv e/ou diagnóstico de hepatite c, composição, uso de pelo menos um polipeptídeo, e, métodos para produzir um polipeptídeo, para triagem imunológica de hcv e para o diagnóstico de hepatite c

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350671A (en) 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
WO1993000365A2 (en) 1991-06-24 1993-01-07 Chiron Corporation Hepatitis c virus (hcv) polypeptides
UA39944C2 (uk) 1992-07-07 2001-07-16 Чірон Корпорейшн Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
US6514731B1 (en) 1996-05-24 2003-02-04 Chiron Corporation Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
US6054424A (en) 1998-04-15 2000-04-25 Church & Dwight Co., Inc. Process for the production of a liquid laundry detergent composition of desired viscosity containing nonionic and anionic surfactants
ES2281179T3 (es) 1998-06-09 2007-09-16 Andrea D. Branch Nuevos peptidos del virus de la hepatitis c y usos de los mismos.
CA2389206C (en) 1999-10-27 2011-01-04 Chiron Corporation Activation of hcv-specific t cells
CA2390082C (en) * 1999-11-24 2010-06-29 Chiron Corporation Novel hcv non-structural polypeptide
CA2491508A1 (en) * 2002-07-02 2004-01-15 Chiron Corporation Hcv fusion proteins with modified ns3 domains
WO2004039950A2 (en) 2002-10-25 2004-05-13 Chiron Corporation Activation of hcv-specific cells
NZ551319A (en) 2004-05-17 2010-07-30 Novartis Vaccines & Diagnostic Truncated Hepatitis C virus NS5 domain and fusion proteins comprising same
ES2377978T3 (es) 2004-08-27 2012-04-03 Novartis Vaccines And Diagnostics, Inc. Mutantes de proteínas no estructurales de VHC y usos de los mismos

Similar Documents

Publication Publication Date Title
JP2006149406A5 (https=)
JP2008529558A5 (https=)
JP2010532656A5 (https=)
JP2009515831A5 (https=)
JP2014507144A5 (ja) 慢性ｂ型肝炎感染症のための酵母系免疫療法組成物
JP2011528222A5 (https=)
JP2008536483A5 (https=)
JP2009268467A5 (https=)
JP2011528896A5 (https=)
JP2012095652A5 (https=)
JP2021519599A5 (https=)
JP2010535026A5 (https=)
JP2012516140A5 (https=)
JP2007502101A5 (https=)
JP2012501347A5 (https=)
WO2007143442A3 (en) A novel virulence determinant within the e2 structural glycoprotein of classical swine fever virus
RU2008135433A (ru) Гибриды рекомбинантных антител-белков стресса
JP2014523878A5 (https=)
CA2389206A1 (en) Activation of hcv-specific t cells
JP2008507298A5 (https=)
JP2006518331A5 (https=)
JP2010508276A5 (https=)
JP2011528897A5 (https=)
JP2010501580A5 (https=)
JP2005532064A5 (https=)